What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
. Mini Rev Med Chem. 2021 Feb 19. doi: 10.2174/1389557521666210219161747. Online ahead of print. Mini Rev Med Chem. 2021. PMID: 33605857